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Abstract
Background: The present work aims to investigate the antioxidant and antimicrobial activities as well as the
potential of DCS1 lipopeptides produced by Bacillus methylotrophicus DCS1 strain at inhibition and disruption of
biofilm formation.
Results: The produced biosurfactants were characterized as lipopeptides molecules by using thin layer
chromatography (TLC) and Fourier transform infrared spectroscopy (FT-IR). The DCS1 lipopeptides were assayed for
their antioxidant activity through five different tests. The scavenging effect on DPPH radicals at a concentration of
1 mg mL−1 was 80.6%. The reducing power reached a maximum value of 3.0 (OD700 nm) at 2 mg mL
−1. Moreover,
the DCS1 lipopeptides exhibited a strong inhibition of β-carotene bleaching by linoleic acid assay with 80.8% at
1 mg mL−1 and showed good chelating ability and lipid peroxidation inhibition. The in vitro antimicrobial activity
of DCS1 lipopeptides showed that they display significant antibacterial and antifungal activities. The anti-adhesive
activity of DCS1 lipopeptides was evaluated against several pathogenic microorganisms. The lipopeptides showed
excellent anti-adhesive activity, even at low concentrations, in a polystyrene surface pre-treatment against all the
microorganisms tested. Further, they can disrupt performed biofilms.
Conclusion: This study shows the potentiality of DCS1 lipopeptides as natural antioxidants, antimicrobial and/or
anti-adhesive agent for several biomedical and industrial applications.
Keywords: Bacillus methylotrophicus DCS1, Lipopeptides like substances, Antioxidant, Antimicrobial, Anti-adhesive
activities
Background
Bacteria are the main group of biosurfactants producing
microorganisms [1]. Several studies have reported the
potential of Bacillus species as biosurfactant producers
such as lipopeptide type biosurfactants [2]. These are
amphiphilic cyclic peptides that are linked to a fatty acid
hydrocarbon chain and they belong to the surfactin,
iturin and fengycin families. They are synthesized by
non-ribosomal peptide synthetases without involving
messenger RNA [3]. Lipopeptides were found to have
specific biological activities, such as antioxidant [4, 5],
antimicrobial [6–8], and antitumor activities [9]. The ad-
vantages related to the use of microbial biosurfactants over
their chemical counterparts include their lower toxicity and
higher biodegradability, as well as their effectiveness at dif-
ferent environmental conditions such as extreme pH,
temperature and high ionic strength, in addition to their
biocompatibility [10]. These advantages allow using them
in pharmaceutical, cosmetic and food additives industries
[11]. In the food industry, biosurfactants offer several func-
tions such as emulsifying/foaming agents, stabilizers, anti-
oxidant agents, and anti-adhesives [12, 13].
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Biosurfactants have also been proved to be great inhib-
itors of microbial adhesion and biofilm formation. Bio-
films are communities of microbes adhering to biotic or
abiotic surfaces. Broadly, microbial biofilms are a daily
challenge faced by the food industry and society [14].
Adhesion is the first stage of biofilm formation and the
best time for the action of anti-adhesive compounds [15].
In fact, life in a biofilm probably represents the predomin-
ate mode of growth for microbes in most environments.
The role of biosurfactants in microbial anti-adhesion and
desorption has been widely described, and adsorption of
biosurfactants to solid surfaces can be an effective strategy
to reduce microbial adhesion and combating colonization
by pathogenic microorganisms [16, 17].
This report represents an investigation of the antioxi-
dant, antimicrobial and anti-adhesive activities of lipopep-
tides produced by Bacillus methylotrophicus DCS1 strain.
Methods
Microorganism
Biosurfactant-producing strain used in this study was
isolated from hydrocarbon contaminated soil in Sfax
City, Tunisia. It was selected on the basis of the high
hemolytic activity and decreasing surface tension of the
culture medium from 72 mN m−1 to 31 mN m−1. This
strain was identified as Bacillus methylotrophicus DCS1
based on its biochemical and 16S rDNA gene sequence
analysis [18]. The bacterial strain was maintained at 4 °C
and also preserved in glycerol at −80 °C.
Production media
Bacillus methylotrophicus DCS1 was inoculated into a
250 mL Erlenmeyer flask containing 25 mL Luria-Bertani
(LB) broth medium (g L−1): peptone, 10.0; yeast extract,
5.0; and NaCl, 5.0; pH 7.0. Culture was incubated at 37 °C
with shaking at 200 rpm for 18 h. A 3% (v/v) of inoculum
[OD600 nm = 7.6] was transferred into a 2 L Erlenmeyer
flask containing 250 mL of Landy medium [19] which con-
tains: glucose 20 g L−1, L-glutamic acid 5 g L−1, yeast ex-
tract 1 g L−1, K2HPO4 1 g L
−1, MgSO4 0.5 g L
−1, KCl 0.5 g
L−1, CuSO4 0.0016 g L
−1, Fe2 (SO4)3 0.0004 g L
−1, MnSO4
0.0012 g L−1. The initial pH of the medium was adjusted to
7.0 and culture was incubated for 72 h at 30 °C with shak-
ing at 150 rpm.
Biosurfactant recovery
The culture medium was centrifuged at 8000 rpm and
4 °C for 20 min to remove bacterial cells. Supernatant
free-cell was subjected to acid precipitation with 6 N
HCl until pH 2.0, then left overnight at 4 °C with agita-
tion. The precipitate was collected by centrifugation at
8000 rpm, for 20 min at 4 °C, suspended in distilled
water and the pH was adjusted to 8.0 with NaOH
(1.0 N) [20]. The crude biosurfactants obtained was
lyophilized.
Thin layer chromatography
The extracted biosurfactants were analyzed on silica
plates 60 F (Merck, Macherel-Nagel) with a solvent sys-
tem consisting of (chloroform: methanol: water) solution
in the ratio (65:25:4). The compounds on the plate were
detected after spraying with the ninhydrin reagent and
iodine vapor which respectively detected the peptide and
lipid parts in the biosurfactants [21].
FT-IR spectra of the dried biosurfactants
Fourier transform infrared spectroscopy (FT-IR) was used
to determine the functional groups and the chemical bonds
present in the biosurfactants extract and then to determine
its chemical nature. The FT-IR analysis was realized by
using Analect Instruments fx-6160 FT-IR spectrometer.
1 mg of lyophilized sample was ground in about
100 mg of spectral grade KBr and pressed for 30 s to
obtain translucent pellets. The spectral measurements
were carried out in the absorbance mode. The FTIR
spectrum of the prepared biosurfactants was recorded
between 400 and 4000 cm−1.
Antioxidant activities
DPPH radical-scavenging assay
The 2, 2-diphenyl-1-picrylhydrazyl (DPPH) free radical-
scavenging potential of DCS1 lipopeptides at different
concentrations (0.1–2 mg mL−1) was determined accord-
ing to the report of Bersuder et al. [22]. The DPPH rad-
ical scavenging activity was calculated as follows:
DPPH radical‐scavenging activity %ð Þ
¼ Acontrol þ Ablanc−Asample
Acontrol
 100
where Acontrol is the absorbance of the control reaction
(containing all reagents except lipopeptides), Ablank is
the absorbance of lipopeptides (containing all reagents
except the DPPH solution) and Asample is the absorbance
of lipopeptides with the DPPH solution.
Lower absorbance of the reaction mixture indicated
higher DPPH radical-scavenging activity. BHA (2.0 mM)
was used as positive standard. The test was carried out
in triplicate and the results are mean values.
The effective concentration of DCS1 lipopeptides re-
quired to scavenge DPPH radical by 50% (IC50 value)
was obtained by linear regression analysis of dose-
response curve plotting between percentage of DPPH
radical-scavenging activity and concentrations.
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Ferric-reducing activity
The ability of DCS1 lipopeptides at different concentra-
tions (0.1 to 3 mg mL−1) to reduce iron III was deter-
mined according to the method of Yildirim et al. [23]. All
data values presented are the mean of triplicate analyses.
Ferrous ion-chelating activity
The Fe2+ chelating activity of DCS1 lipopeptides at dif-
ferent concentrations (0.5–5 mg mL−1) was estimated by
the method of Carter [24]. The percentage of inhibition
of ferrozine–Fe2+ complex formation was calculated
using the following formula:
Ferrous ion‐chelating activity %ð Þ
¼ Acontrol þ Ablanc−Asample
Acontrol
 100
where Acontrol is the absorbance of the control (without
sample), Ablank is the absorbance of the blank (without
ferrozine) and Asample is the absorbance of the sample.
Ethylene diamine tetra acetic acid (EDTA) was used as
positive control and the test was carried out in triplicate.
β-carotene bleaching assay
The capacity of DCS1 lipopeptides to prevent bleaching of
β-carotene at different concentrations (0.025–1 mg mL−1)
was evaluated as described by Koleva et al. [25]. The anti-
oxidant activity was calculated in terms of β-carotene
bleaching inhibition using the following formula:
β‐carotene bleaching inhibition
¼ 1− A0−At
A
0
0−A
0
t
  
 100
where A0 and A’0 are the absorbances of the test sample
and the control, respectively, measured at time zero; and At
and A’t are the absorbance of the sample and the control,
respectively, measured after incubation. BHA was used as a
positive standard. Tests were performed in triplicate and
values presented are the mean of triplicate analyses.
The half maximal inhibitory concentration (IC50) is the
concentration where 50% inhibition of the β-carotene
bleaching radical is obtained. IC50 value was obtained by
linear regression analysis of dose-response curve plotting
between percentage of inhibition and concentrations.
Inhibition of linoleic acid peroxidation
In vitro lipid peroxidation inhibitory activity of lipopep-
tides like substances DCS1 was determined by evaluating
their ability to inhibit oxidation of linoleic acid in an
emulsified model system. DCS1 lipopeptides at 0.1 mg
mL−1 concentration were dissolved in 2.5 mL of distilled
water and added to 2.5 mL of ethanol and 32.5 μL lino-
leic acid. The final volume was then adjusted to 6.25 mL
with distilled water. The mixture was incubated in a
10 mL tube with silicone rubber caps at 45 °C for 9 days
in dark. Vitamin C, a natural antioxidant agent, was used
as a positive control, and distilled water as negative con-
trol. Lipid peroxidation was estimated as evidenced by
the formation of thiobarbituric acid reactive substances
(TBARS) such as malondialdehyde (MDA). TBARS were
tested in samples by the method described by Yagi [26].
MDA and other TBARS were measured by their reactiv-
ity with TBA in an acidic condition to generate pink col-
ored chromospheres which was read at 530 nm. A
sample (375 μL) was homogenized with 150 μL of TBS
(50 mM Tris containing 150 mM NaCl, pH 7.4) and
375 μL of TCA 20% (w/w) in order to precipitate pro-
teins, and then centrifuged (1000 g, 10 min, 4 °C). A
400 μL of the supernatant was mixed with 80 μL of HCl
(0.6 M) and 320 μL of Tris–TBA (Tris 26 mM; TBA
120 mM), and the mixture was heated for 10 min at 80 °C.
The absorbance of the resulting solution was read at
530 nm. Inhibition of linoleic acid peroxidation was esti-
mated by the following formula:
Inhibition of linoleic acid peroxidation
¼ 1−Asample
Acontrol
 
 100
where Asample was the absorbance of the sample and
Acontrol was the absorbance of the control (replacing the
sample by water).
Antimicrobial activities
Microbial strains
Antibacterial activity of DCS1 lipopeptides was tested
against three Gram-positive bacteria: Staphylococcus
aureus (ATCC 25923), Bacillus cereus (ATCC 11778),
Micrococcus luteus (ATCC 4698) and five Gram-negative
bacteria: Klebsiella pneumoniae (ATCC 13883), Escherichia
coli (ATCC 25922), Salmonella typhimurium (ATCC
19430), Salmonella enterica (ATCC 27853) and Enterobac-
terium sp.
Antifungal activity was tested using Aspergillus niger,
Aspergillus flavus, Fusarium oxysporium, Pythium ultiu-
mum, Fusarium solani and Rhizoctonia bataticola.
Agar diffusion method
DCS1 lipopeptides were tested in vitro for antimicrobial
activities by conventional agar diffusion method against
human pathogens [27].
Using sterile pipette, culture suspension (200 μL) of
the tested microorganisms (106 colony-forming units
CFU mL−1) of bacteria cells (estimated by absorbance at
600 nm) and 108 spores mL−1 of fungal strains (measured
by Malassez blade) were spread uniformly on Luria-
Bertani agar and malt extract agar media, respectively.
Then, wells were made using a sterile well borer and were
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filled with 100 μL of lipopeptides sample (2 mg mL−1
concentration).
The zone of growth inhibition was measured in milli-
metres after incubation for 24 h at 37 °C for bacteria
and for 72 h at 30 °C for fungal strains. All the results
were represented as the average of three independent
experiments.
Effect of proteolytic enzymes, heat, and pH on crude
lipopeptides antibacterial activity
The susceptibility of the crude lipopeptides to proteo-
lytic enzymes, heat and pH treatments was assessed as
described elsewhere [28]. To evaluate its stability to pro-
teolytic enzymes, the crude lipopeptides sample (2 mg
mL−1 concentration) was incubated at 37 °C for 60 min
with 1 mg mL−1 final concentration of trypsin, chymo-
trypsin and pepsine. To analyze thermal stability, sam-
ples were incubated at temperatures ranging 40, 60, 80
and 100 °C for 20 min. The effect of pH on DCS1 lipo-
peptides activity was studied by assaying antibacterial ac-
tivity against K. pneumoniae, the pH was adjusted at
values from 3.0 to 10.0. Samples were neutralized to
pH 7.0 before measurement of the antibacterial activity,
the following buffer systems were used: 100 mM gly-
cine–HCl buffer, pH 3.0–4.0; 100 mM acetate buffer,
pH 4.0–6.0; 100 mM Tris–HCl buffer, pH 7.0–8.0 and
100 mM glycine–NaOH buffer, pH 9.0–10.0. After the
treatments, residual antibacterial activity against K.
pneumoniae was determined as follows:
Residual antibacterial activity %ð Þ
¼ Zone of growth inhibition after treatment
Zone of growth inhibition without treatment
 100
Anti-adhesion treatment with lipopeptides extract DCS1
The anti- and post-adhesion treatments were studied
with lipopeptides extract obtained as follows: acid-
precipitated lipopeptides (1 g) was subjected to extrac-
tion with 25 ml tetrahydrofuran (THF) solvent four
times and the mixture was stirred and centrifuged at
8000 rpm, for 15 min at 4 °C. The organic phases recu-
perated were combined and evaporated to dryness in a
rotary vacuum evaporator (Büchi, Switzerland) at 40 °C,
and then lipopeptides extract was suspended in distilled
water and lyophilized.
For surface pre-treatment, the wells of a sterile micro-
titer plate were loaded with 200 μL of DCS1 lipopeptides
extract at different concentrations ranging from 0.016 to
2 mg mL−1, dissolved in PBS (pH 7.2). Micro-titer plates
were incubated for 6 h at room temperature (25 °C) and
then washed twice with PBS.
For biofilm formation, Salmonella typhimurium ATCC
14028, Klebsiella pneumoniae ATCC 13883, Staphylococcus
aureus ATCC 25923, Bacillus cereus ATCC 11778 and
Candida albicans ATCC 10231 were cultured overnight in
Luria-Bertani medium (LB). Cultures were diluted 1/100 in
the medium proposed by O′Toole [29] (g L−1): glucose, 2;
casamino acids, 5; KH2PO4, 3; K2HPO4, 7; (NH4)2SO4, 2,
MgSO4 7H2O, 0.12. Then, 200 μL of each dilution were
added to the micro-titer plate wells and incubated for 20 h
at 37 °C. After incubation, wells were washed three times
with distilled water to remove non-adherent cells, fixed for
15 min with methanol and stained with 125 μL crystal vio-
let (CV) (0.1%) for 20 min, then washed with water and
dryed. For quantifying the microbial adhesion, the stain in
the wells was diluted with 200 μL acetic acid in water (33%)
and the absorbance was determined at 595 nm [13]. Per-
centages of microbial adhesion inhibition were calculated
using the formula:
Microbial adhesion inhibition ¼ ½1ðAc=A0Þ  100
where Ac represents the absorbance of the well with
lipopeptides at concentration c and A0 represents the
absorbance of the positive control wells (in absence
of lipopeptides). Negative control wells contained only
lipopeptides dissolved in PBS. Assays were carried out
three times.
Mature biofilm treatment with lipopeptides extract DCS1
The wells of a polystyrene micro-titer plates were filled
with 200 μL of bacterial suspension prepared as de-
scribed above, and then the plates were incubated for
20 h at 37 °C. After incubation, the unattached microbial
cells were removed by washing the wells three times
with distilled water. Thereafter, 200 μL of DCS1 lipopep-
tides at different concentrations ranging from 0.016 to
2 mg mL−1, were added to each well and the plates were
incubated for 6 h at room temperature (25 °C). The
quantification was realized as in the pre-treatment. All
the results were represented as the average of three in-
dependent experiments.
All data presented are the average of at least three
measurements which deviated by not more than 5%.
Results and discussion
Preliminary chemical characterization
TLC analysis separates compounds in a mixture and can
be used to determine the number of components in so-
lutions. The sample of crude biosurfactants revealed yel-
low spots with iodine vapour, suggesting the presence of
polar lipids. Treatment with ninhydrin revealed pink
spots suggesting the presence of protein portions. The
presence of both protein units and lipid moieties on the
same spot suggested that the sample is a lipopeptide
type. Similar results for other lipopeptide type biosurfac-
tant were also reported elsewhere [30].
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The IR spectrum of the crude biosurfactants DCS1
was analyzed to gain insight into its chemical nature
(Fig. 1). A broad absorbance with wave numbers ranging
approximately from 3700 cm−1 to 3000 cm−1 having its
maximum at 3297 cm−1 was detected. Absorbance in this
region is a result of -CH and -NH stretching vibrations,
and it is a characteristic of carbon-containing compounds
with amino groups [31]. Other sharp absorbance peaks are
seen at 2959, 2928 and 2855 cm−1, indicating the presence
of –C-CH3 banding or long alkyl chains [32]. The peak with
highest absorbance in the spectrum was observed at
1651 cm−1. Absorbance in this region signifies the presence
of peptide groups in the molecules [33]. Another high in-
tensity peak at 1537 cm−1, corresponded to the deformed
N–H band. The weak band at 1398 cm−1 in the absorption
range 1370–1470 cm−1 could result from deformation and
bending vibrations of –C-CH2 and –C-CH3 groups in
aliphatic chains [34]. Peaks at 1234 and 1111 cm−1
are probably due to the presence of C-O-C vibrations
in esters [32, 33].
The observed peaks are those commonly found in the
IR spectra of lipopeptide biosurfactants produced by sev-
eral species [21, 35, 36].
Antioxidant activities
DPPH radical-scavenging assay
The DPPH radical-scavenging assay has been generally
used to study the ability of compounds to act as free
radical scavengers or hydrogen donors [37]. When DPPH
encounters a hydrogen-donating substance, the radical
would be scavenged, as visualized by changing its
color from purple to yellow, and the absorbance is re-
duced [38]. The stable DPPH radical displays a
maximum absorbance at 517 nm in ethanol. As dis-
played in Fig. 2a, the DCS1 lipopeptides exhibited ef-
fective antioxidant activity against DPPH in a dose
dependent manner. In fact, at 1 mg mL−1, the DCS1
lipopeptides showed a potential scavenging effect of
80.6%, which is three-times higher than that obtained at
0.1 mg mL−1 (25.9%). Our results are in accordance with
previous works of Yalçin and Ҫavuşoǧlu [39] who reported
that the DPPH scavenging activity increased with increas-
ing the concentration of biosurfactant synthesized by
Bacillus subtilis RW-I.
However, DCS1 lipopeptides exhibited lower radical-
scavenging activity than did BHA used as reference at
the same concentrations. The IC50 value was about
357 μg mL−1. Scavenging effect can be assigned to the
presence of the hydrocarbon fatty acid chain and some
active residues in the peptide ring, which acted as a good
hydrogen atom or an electron donor and could react
with free radicals of DPPH.
Ferric reducing antioxidant power
The reducing power of a compound may serve as a signifi-
cant indicator of its potential antioxidant activity [40]. In
this test, the presence of reducers causes the reduction of
the Fe3+/ferricyanide complex to the ferrous form. The
reductive activity of DCS1 lipopeptides as well as the syn-
thetic antioxidant BHA as a function of their concentra-
tions is illustrated in Fig. 2b. The reducing capacity of
DCS1 lipopeptides increased with increasing their concen-
tration. It indicates a dose-dependent response and reached
a maximum of 3.0 (OD700 nm) at a concentration of 2.0 mg
mL−1. The obtained values are lower than those of BHA at
concentrations below 2.0 mg mL−1.
Fig. 1 Fourier transforms infrared spectrum of biosurfactants produced by Bacillus methylotrophicus DCS1
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The reductive ability of DCS1 lipopeptides is higher than
those of lipopeptides produced by Bacillus mojavensis A21
which reached 2.0 (OD700 nm) at a concentration of 10 mg
mL−1 [5] and surfactin lipopeptide produced by B. subtilis
RW-I, which reached 2.0 (OD700 nm) at a concentration of
2.5 mg mL−1 [39]. Yalçin and avuşo lu [39] reported
that the reductive ability could be related to the presence
of hydroxyl groups in the lipopeptides molecules.
Ferrous ion-chelating activity
Ferrous ion (Fe2+) is the most potent pro-oxidant among
metal ions. This ion can interact with hydrogen peroxide
in a Fenton reaction to produce the reactive oxygen
species and hydroxyl free radical (OH), leading to the
initiation and/or acceleration of lipid oxidation [41].
Chelating agents may inhibit lipid oxidation by stabiliz-
ing transition metals. Measurement of color reduction
allows, therefore, estimating the metal chelating activity
of the co-existing chelator [42].
The Fe2+ chelating capacity of DCS1 lipopeptides
against Fe2+ was determined by measuring the iron fer-
rozine complex. As shown in Fig. 2c, DCS1 lipopeptides
exhibited strong ferrous-chelating activity and chelated
almost 79.8% of ferrous ions at 4 mg mL−1. However,
DCS1 lipopeptides exhibited lower metal chelating
activity than EDTA, a well-known metal ion chelator.
The obtained results suggest that some lipopeptide
isoforms could be potential antioxidant through metal
chelating ability.
β-carotene bleaching assay
The antioxidant assay using the discoloration of β-
carotene is widely used to measure the antioxidant activ-
ity of bioactive compounds. The β-carotene bleaching
inhibition was tested at different concentrations and
compared with BHA. As shown in Fig. 2d, the DCS1
lipopeptides inhibited significantly the discoloration of
β-carotene and its antioxidant activity increased with in-
creasing sample concentration. The inhibitor concentra-
tion IC50 was estimated to be 42 μg mL
−1. However
BHA has better β-carotene bleaching inhibition than
that of DCS1 lipopeptides at all concentrations tested.
DCS1 lipopeptides are more effectives than A21 lipopep-
tides, which showed a β-carotene bleaching inhibition of
72% at 10 mg mL−1 concentration and the IC50 was esti-
mated to be 3.7 mg mL−1 [5].
Inhibition of linoleic acid peroxidation
Antioxidant activity of DCS1 lipopeptides, at a concen-
tration of 0.1 mg mL−1, against the peroxidation of
a
b d
c
Fig. 2 Scavenging effect on DPPH free radical (a), ferric-reducing antioxidant power (b), ferrous-ion chelating activity (c) and β-carotene bleaching
assay (d) of DCS1 lipopeptides at different concentrations. BHA and EDTA (2.0 mM) were used as positive control. Values presented are the mean
of triplicate analysis. Lipopeptides DCS1 BHA EDTA
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linoleic acid during 3, 6 and 9 days of storage at 45 °C,
was evaluated and compared to that of vitamin C, used
as a natural antioxidant (Fig. 3). After 3 days of incuba-
tion period, DCS1 lipopeptides displayed a lipid peroxi-
dation inhibition of about 60.22%, and reached about
76.8% after 9 days. The vitamin C showed higher pro-
tective effect than biosurfactants. The inhibitory effect
could be explained by the presence of acyl chain of fatty
acids by improving the interaction between lipopeptide
like substances and linoleic acid [5]. The crude lipopep-
tides synthesized by B. methylotrophicus DCS1 strain
can be an important potential source of antioxidants.
Antimicrobial activity of DCS1 lipopeptides
The antimicrobial activity of DCS1 lipopeptides, against
various microorganisms, was estimated by agar well
diffusion method and the results are summarized in
Table 1. Lipopeptides were effective against several
tested bacteria with different degrees. The highest anti-
bacterial activity was observed against K. pneumoniae,
with a maximum zone diameter inhibition of 30 mm at
a concentration of 2 mg mL−1, while the lowest activity
was detected against Enterobacterium sp. However,
DCS1 lipopeptides did not exhibit antimicrobial activity
against M. luteus at 2 mg mL−1. Several lipopeptide bio-
surfactants obtained from Bacillus amyloliquefaciens M1
[8] and Bacillus mojavensis A21 [7] showed strong anti-
bacterial activity.
Regarding the antifungal activity, DCS1 lipopeptides
showed a significant activity against various fungal strains.
Higher activity was observed against A. niger and A. fla-
vus, less activity was against P. ultimum, F. solani and R.
bataticola, no effect was observed on F. oxysporium.
Donio et al. [43] reported that Bacillus sp. BS3’s biosurfac-
tants possess an important antifungal activity against
different pathogens. Sheppard et al. [44] indicated that
lipopeptide biosurfactants interact with the cell membrane
of the target cells and exhibit significant antimicrobial
properties.
Effect of proteolytic enzymes, heat and pH on
lipopeptides antibacterial activity
The resistance of lipopeptides against proteases and ex-
treme conditions, including temperature and pH was a
prerequisite for their potential therapeutic and pharma-
ceutical applications. DCS1 lipopeptides retained their
antibacterial activity against K. pneumoniae after incuba-
tion for 1 h with proteolytic enzymes pepsin, trypsin and
chymotrypsin at a concentration of 1 mg mL−1 (Table 2).
These results exclude the eventual existence of
bacteriocin-like substances in the crude lipopeptides and
they indicate that the antimicrobial compounds could be
cyclic peptides containing unusual amino acids [45].
Regarding thermostability, DCS1 lipopeptides were re-
sistant to heating for 20 min at temperatures up to 100 °
C retaining 100% their initial activity (Table 2). The
maintenance of antimicrobial activity after treatment
with proteolytic enzymes and after incubation at a wide
range of temperature resembles the characteristics of
cyclic lipopeptides of Bacillus sp. [46].
Antimicrobial activity was also tested at different pH
values. The antimicrobial substance was active at pH 8.0
and pH 10.0, retaining 100% of the activity, while at
pH 5.0 and 3.0 the activity was decreased (84.4% and
74% of its initial activity at pH 5.0 and pH 3.0, respect-
ively). The decrease in antibacterial activity could be due
to partial precipitation of lipopeptides.
Anti-adhesive activity
Biosurfactants are known to decrease the adhesion of
pathogenic microorganisms to solid surfaces [47]. Thus,
the anti-adhesive activity of DCS1 lipopeptides was
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Fig. 3 Inhibition of linoleic acid peroxidation by DCS1 lipopeptides. 3 days 6 days 9 days
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investigated against five strains. As can be seen in
Fig. 4a, the pre-treatment of polystyrene surfaces with
DCS1 lipopeptides significantly inhibited the adhesion of
all tested bacteria, even at low concentrations. The biofilm
formation inhibition was concentration-dependent, and
the anti-adhesive effect remains nearly constant above a
concentration of 1 mg mL−1 lipopeptides. The highest
anti-adhesive effect was observed against C. albicans with
an inhibition percentage of about 89.3%. Our results are
in accordance with those of Janek et al. [15] who reported
that the pre-treatment of a polystyrene surface with
0.5 mg mL−1 pseudofactin II inhibited bacterial adhe-
sion by 36–90% and that of C. albicans by 92%. In
another study, Coronel-león et al. [13] reported that
the highest anti-adhesive activity of the biosurfactant
lichenysin produced by Bacillus licheniformis AL1.1
was observed against C. albicans (74.35%) at a con-
centration of 4 mg mL−1.
High anti-adhesion effect was also observed for S. aur-
eus, B. cereus and S. typhimurium (77.3, 77.1 and 75.7%,
respectively, at 1 mg mL−1) with DCS1 lipopeptides,
while the effect on K. pneumoniae was low (50%).
Gudiña et al. [47] demonstrated high anti-adhesion ac-
tivity against many pathogens, among them S. aureus
(72.0%), Staphylococcus epidermidis (62.1%) and Srepto-
coccus agalactiae (60%), but at high concentration of
biosurfactant produced by Lactobacillus paracasei A20
(25 mg mL−1). Earlier reports [48] described the inhib-
ition of pathogenic bacteria adhesion (Escherichia coli
CFT073 and S. aureus ATCC 29213) to polystyrene
surfaces by two lipopeptide biosurfactants synthesized by
Bacillus subtilis and Bacillus licheniformis. Furthermore,
Pontibacter korlensis SBK-47 strain produces pontifactin, a
new lipopeptide biosurfactant that exhibits anti-adhesive
activity against many pathogenic bacteria ranging from
87% to 99% inhibition at a maximum concentration of
2 mg mL−1 [36].
DCS1 lipopeptides exhibit high efficiency as the calcu-
lated effective dose (ED50) with 50% adhesion inhibition
was very low with all microorganisms tested: 0.36 mg mL−1
for S. typhimurium, 2 mg mL−1 for K. pneumoniae, 0.4 mg
mL−1 for B. cereus and 0.015 mg mL−1 for S. aureus.
The inhibition of biofilm formation is due to the cap-
acity of lipopeptides to modify the physico-chemical prop-
erties of the surface to reduce adhesion and biofilm
formation. Some lipopeptides are considered anionic due
to the negative charges of amino acids, also surfaces of
most bacterial cells are negatively charged. Therefore, in
the pre-treatment with lipopeptides, the potential effect of
biofilm formation inhibition could be the result of the
electrostatic repulsion forces between the negative charge
of polystyrene surface recovered with lipopeptides mole-
cules and negative charge of the microbial membrane.
Bacterial adhesion depends on bacterial charge, surface
type and on the biosurfactant charge which interferes in
their influences.
Disruptive activity on pre-formed biofilm
Disruption of biofilm consists in removing the attached
microorganisms from the surface after biofilm formation.
Table 2 Influence of proteolytic enzymes, temperature and pH
on DCS1 lipopeptides antibacterial activity against K. pneumoniae
Treatment Residual activity (%)
Enzyme (1 mg mL−1)
Pepsin 100
Trypsin 100
Chymotrypsin 100
Temperature (°C)
40 100
60 100
80 100
100 100
pH
3 74
5 84
8 100
10 100
Residual activity compared with the antimicrobial activity before the treatment.
Data are means of three independent experiments
Table 1 Antimicrobial activity spectrum of DCS1 lipopeptides
(2 mg mL−1)
Indicator organisms Inhibition zone diameter (mm)
Gram (+)
S. aureus (ATCC 25923) 14 ± 0.4
B. cereus (ATCC 11778) 15 ± 0.1
M. luteus (ATCC 4698) −
Gram (−)
K. pneumoniae (ATCC 13883) 30 ± 0.1
E. coli (ATCC 25922) 16.5 ± 0.6
S. typhimyrium (ATCC 19430) 15 ± 0.2
S. enterica (ATCC 27853) 15 ± 0.1
Enterobacterium sp. 7.66 ± 0.6
Fungi
A. niger +++
A. flavus +++
F. oxysporium −
P. ultimum ++
F. solani ++
R. bataticola ++
Determinations were performed in triplicate and data correspond to mean
values ± standard deviations
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As illustrated in Fig. 4b, the efficacy of biofilm disruption
increased with increasing sample concentration, and the
percentages of disruption remain nearly constant above a
concentration of 1 mg mL−1 lipopeptides. The maximum
disruption produced by DCS1 lipopeptides was observed
for C. albicans with 89.50%, followed by S. aureus (77%),
S. typhimurium (75%), B. cereus (74.8%) and K. pneumo-
niae (50.3%). Our results are in agreement with those of
Dalili et al. [12] who reported that Coryxin, a cyclic
lipopeptide, produced by Corynebacterium xerosis NS5
displayed inhibitory and disruptive activities against bio-
film formation by a variety of bacteria.
The effectiveness of lipopeptides in post-treatment of
biofilm formation using various microorganisms was
similar to that in pre-treatment. Our findings are in
contrast with those of Janek et al. [15] who stated that
the effectiveness in biofilm disruption in a post-treatment
is lower than in biofilm inhibition in a pre-treatment
with an activity ranging from 26 to 70% with pseudo-
factin II (0.5 mg mL−1).
The effective dose (ED50) was very low in post-
treatment with all pathogens tested: 0.51 mg mL−1 for S.
typhimurium, 2 mg mL−1 for K. pneumoniae, 0.11 mg
mL−1 for S. aureus, 0.37 mg mL−1 for B. cereus and
0.096 mg mL−1 for C. albicans.
The disruption of biofilm could be explained by the
adsorption of lipopeptides at the interface between
the attached biofilm-forming bacteria and the solid sur-
face, thus favoring bacterial detachment. According to
McLandsborough et al. [49], surfactants could penetrate
and adsorb at the interface between the solid surface and
the biofilm owing to their high surface activity and reduce
the interfacial tension.
When comparing both processes, pre-treatment and
post-treatment of polystyrene surfaces, it is clear that the
action of DCS1 lipopeptides was more effective against C.
albicans. The use of the yeast C. albicans is of particular
interest because it is recognized as an important pathogen
in nosocomial infections [50]. Also DCS1 lipopeptides
could be considered as a good alternative for controlling
a
b
Fig. 4 Effect of DCS1 lipopeptides at different concentrations on biofilm formation inhibition (a) and disruption (b). Staphylococcus aureus
Salmonella typhimurium Klebsiella pneumoniae Candida albicans Bacillus cereus
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the growth of biofilms of S. typhimyrium, S. aureus and B.
cereus which are responsible for opportunistic food-borne
illness.
Conclusion
The current study demonstrated that lipopeptides syn-
thesized by B. methylotrophicus DCS1 strain exerted
considerable antioxidant action involving several antioxi-
dant mechanisms, including metal ion chelating, hydro-
gen or electron donation and radical scavenging during
peroxidation. Further, the DCS1 lipopeptides showed
antimicrobial activities against several microorganisms
tested. In addition, they showed anti-adhesive activity
against biofilm formation as well as their potential to
disrupt pre-formed biofilm. The results obtained suggest
the possible use of DCS1 lipopeptides as a potential anti-
oxidant and antimicrobial as well as anti-adhesive agent
to reduce microbial adhesion and biofilm formation in
biomedical field and food industry.
Abbreviations
BHA: Butylhydroxyanisol; CFU: Colony-forming units; CV: Crystal violet;
DPPH: 2, 2-diphenyl-1-picrylhydrazyl; ED50: Effective dose; EDTA: Ethylene
diamine tetra acetic acid; FT-IR: Fourier transform infrared spectroscopy;
IC50: Half maximal inhibitory concentration; LB: Luria-Bertani media;
MDA: Malondialdehyde; OD: Optical density; PBS: Phosphate-buffered saline;
rDNA: Ribosomal Deoxyribonucleic acid; RNA: Ribonucleic acid;
TBARS: Thiobarbituric acid reactive substances; THF: Tetrahydro-furan;
TLC: Thin layer chromatography
Funding
This work was funded by the Ministry of Higher Education and Scientific
Research, Tunisia. This work was partially financed by the Ministerio de
Economía y Competitividad. Spain, project CTQ2014–59632-R, and by the IV
Pla de Recerca de Catalunya, Spain (Generalitat de Catalunya), grant
2014SGR-534.
Availability of data and materials
All data generated or analysed during this study are included in this
published article.
Authors’ contributions
NJ conceived and performed all in vitro experiments. HB-A analyzed and inter-
preted the data. AM analyzed and interpreted the results of anti-adhesion assay.
NJ wrote the manuscript. AM, HB-A, NH and MN contributed in revising the
manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Author details
1Laboratoire de Génie Enzymatique et de Microbiologie, Université de Sfax,
Ecole Nationale d’Ingénieurs de Sfax, B.P, 1173-3038 Sfax, Tunisia. 2Section of
Microbiology, Department of Biology, Health and Environment, Faculty of
Pharmacy, University of Barcelona, Joan XXIII s/n, 08028 Barcelona, Spain.
Received: 18 January 2017 Accepted: 14 June 2017
References
1. Femi-Ola TO, Oluwole OA, Olowomofe TO, Yakubu H. Isolation and
screening of biosurfactant-producing bacteria from soil contaminated with
domestic waste water. BJES. 2015;3:58–63.
2. Joshi SJ, Suthar H, Yadav AK, Hingurao K, Nerurkar A. Occurrence of
biosurfactant producing Bacillus spp. in diverse habitats. ISRN Biotechnol
2013;2013 Article ID 652340, 6 pp.
3. Leclère V, Béchet M, Adam A, Guez JS, Wathelet B, Ongena M, et al.
Mycosubtilin overproduction by Bacillus subtilis BBG100 enhances the
organism's antagonistic and biocontrol activities. Appl Environ Microbiol.
2005;71:4577–84.
4. Tabbene O, Gharbi D, Slimene IB, Elkahoui S, Alfeddy MN, Cosette P, et al.
Antioxidative and DNA protective effects of bacillomycin D-like lipopeptides
produced by B38 strain. Appl Biochem Biotechnol. 2012;168:2245–56.
5. Ben Ayed H, Bardaa S, Moalla D, Jridi M, Maalej H, Sahnoun Z, et al. Wound
healing and in vitro antioxidant activities of lipopeptides mixture produced
by Bacillus mojavensis A21. Process Biochem. 2015;50:1023–30.
6. Benitez LB, Velho RV, da Motta ADS, Segalin J, Brandelli A. Antimicrobial
factor from Bacillus amyloliquefaciens inhibits Paenibacillus larvae, the
causative agent of American foulbrood. Arch Microbiol. 2012;194:177–85.
7. Ben Ayed H, Hmidet N, Béchet M, Chollet M, Chataigné G, Leclère V, et al.
Identification and biochemical characteristics of lipopeptides from Bacillus
mojavensis A21. Process Biochem. 2014;49:1699–707.
8. Xu HM, Rong YJ, Zhao MX, Song B, Chi ZM. Antibacterial activity of the
lipopetides produced by Bacillus amyloliquefaciens M1 against multidrug-
resistant Vibrio spp. isolated from diseased marine animals. Appl Microbiol
Biotechnol. 2014;98:127–36.
9. Damalaon R, Findlay B, Ogunsina M, Arthur G, Schweizer F. Ultrashort
cationic lipopeptides and lipopeptoids: evaluation and mechanistic insights
against epithelial cancer cells. Peptides. 2016;84:58–67.
10. Zheng C, Wang M, Wang Y, Huang Z. Optimization of biosurfactant-
mediated oil extraction from oil sludge. Bioresour Technol. 2012;110:338–42.
11. Md F. Biosurfactant: production and application. J Pet Environ Biotechnol.
2012;3:124.
12. Dalili D, Amini M, Framarzi MA, Fazeli MR, Khoshayand MR, Samadi N. Isolation
and structural characterization of Coryxin, a novel cyclic lipopeptide from
Corynebacterium xerosis NS5 having emulsifying and anti-biofilm activity.
Colloids Surf B Biointerfaces. 2015;135:425–32.
13. Coronel-León J, Marqués AM, Bastida J, Manresa A. Optimizing the
production of the biosurfactant lichenysin and its application in biofilm
control. J Appl Microbiol. 2015;150:99–111.
14. Sadekuzzaman M, Yang S, Mizan MFR, Ha SD. Current and recent advanced
strategies for combating biofilms. Compr Rev Food Sci Food Saf. 2015;14:
491–509.
15. Janek T, Łukaszewicz M, Krasowka A. Antiadhesive activity of the biosurfactant
pseudofactin II secreted by the Arctic bacterium Pseudomonas fluorescens BD5.
BMC Microbiol. 2012;12:24.
16. Nitschke M, Ferraz C, Pastore GM. Selection of microorganisms for biosurfactant
production using agroindustrial wastes. Braz J Microbiol. 2004;35:336–41.
17. Falagas ME, Makris GC. Probiotic bacteria and biosurfactants for nosocomial
infection control: a hypothesis. J Hosp Infect. 2009;71:301–6.
18. Jemil N, Ben Ayed H, Hmidet N, Nasri M. Characterization and properties of
biosurfactants produced by a newly isolated strain Bacillus methylotrophicus
DCS1 and their applications in enhancing solubility of hydrocarbon. World J
Microbiol Biotechnol. 2016;32:175.
19. Landy M, Warren GH, Rosenman SB, Colio LG. Bacillomycin: an antibiotic
from Bacillus subtilis active against pathogenic fungi. Proc Soc Exp Biol Med.
1948;67:539–41.
20. Abouseoud M, Yataghene A, Amrane A, Maachi R. Biosurfactant production
by free and alginate entrapped cells of Pseudomonas fluorescens. J Ind
Microbiol Biotechnol. 2008;35:1303–8.
21. Ibrahim ML, Ijah UJJ, Manga SB, Bilbis LS, Umar S. Production and partial
characterization of biosurfactant produced by crude oil degrading bacteria.
Int Biodeterior Biodegrad. 2013;81:28–34.
22. Bersuder P, Hole M, Smith G. Antioxidants from a heated histidine–glucose
model system. I. Investigation of the antioxidant role of histidine and
isolation of antioxidants by high performance liquid chromatography. J Am
Oil Chem Soc. 1998;75:181–7.
Jemil et al. BMC Microbiology  (2017) 17:144 Page 10 of 11
23. Yildirim A, Mavi A, Kara AA. Determination of antioxidant and antimicrobial
activities of Rumex crispus L. extracts. J Agric Food Chem. 2001;49:4083–9.
24. Carter P. Spectrophotometric determination of serum iron at the submicrogram
level with a new reagent (ferrozine). Anal Biochem. 1971;40:450–8.
25. Koleva II, van Beek TA, Linssen JP, de Groot A, Evstatieva LN. Screening of
plant extracts for antioxidant activity: a comparative study on three testing
methods. Phytochem Anal. 2002;13:8–17.
26. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma.
Biochem Med. 1976;15:212–6.
27. Nanda A, Saravanan M. Biosynthesis of silver nanoparticles from Staphylococcus
aureus and its antimicrobial activity against MRSA and MRSE. Nanomedicine.
2009;5:452–6.
28. Cladera-Olivera F, Caron GR, Brandelli A. Bacteriocin-like substance production
by Bacillus licheniformis strain P40. Lett Appl Microbiol. 2004;38:251–6.
29. O’Toole GA. Microtiter dish biofilm formation assay. J Vis Exp. 2011;47:2437.
30. Alajlani M, Shiekh A, Hasnain S, Brantner A. Purification of bioactive lipopeptides
produced by Bacillus subtilis strain BIA. Chromatographia. 2016;79:1527–32.
31. Kong J, Yu S. Fourier transform infrared spectroscopic analysis of protein
secondary structures. Acta Biochim Biophys Sinica. 2007;39:549–59.
32. Thaniyavarn J, Roongsawang N, Kameyama T, Haruki M, Imanaka T,
Morikawa M, et al. Production and characterization of biosurfactants from
Bacillus licheniformis F2.2. Biosci Biotechnol Biochem. 2003;67:1239–44.
33. Das P, Mukherjee S, Sen R. Antimicrobial potential of a lipopeptide
biosurfactant derived from a marine Bacillus circulans. J Appl Microbiol.
2008;104:1675–84.
34. Dehghan-Noudeh G, Housaindokht M, Bazzaz BS. Isolation, characterization, and
investigation of surface and hemolytic activities of a lipopeptide biosurfactant
produced by Bacillus subtilis ATTC 6633. J Microbiol. 2005;43:272–6.
35. Pereira JFB, Gudina EJ, Costa R, Vitorino R, Teixeira JA, Coutinho JAP, et al.
Optimization and characterization of biosurfactant production by Bacillus
subtilis isolated towards microbial enhanced oil recovery applications. Fuel.
2013;111:259–68.
36. Balan SS, Kumar CG, Jayalakshmi S. Pontifactin, a new lipopeptide biosurfactant
produced by a marine Pontibacter korlensis strain SBK-47: purification,
characterization and its biological evaluation. Process Biochem. 2016;51:2198–207.
37. Uddin SN, Ali ME, Yesmin MN. Antioxidant and antibacterial activities of
Sena tora Roxb. American J Plant Physiol. 2008;3:096–100.
38. Shimada K, Fujikawa K, Yahara K, Nakamura T. Antioxidative properties of
xanthan on the autoxidation of soybean oil in cyclodextrin emulsion. J
Agric Food Chem. 1992;40:945–8.
39. Yalçin E, Ҫavuşoǧlu K. Structural analysis and antioxidant activity of a
biosurfactant obtained from Bacillus subtilis RW1. Turk J Biochem. 2010;35:243–7.
40. Gulcin I, Buyukokuroglu ME, Oktay M, Kufrevioglu OI. On the in vitro
antioxidant properties of melatonin. J Pineal Res. 2002;33:167–71.
41. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free
Radic Biol Med. 1995;18:321–36.
42. Costa LS, Fidelis GP, Cordeiro SL, Oliveira RM, Sabry DA, Câmara RBG, et al.
Biological activities of sulfated polysaccharides from tropical seaweeds.
Biomed Pharmacother. 2010;64:21–8.
43. Donio MBS, Ronica SFA, Thanga Viji V, Velmurugan S, Adlin Jenifer J,
Michaelbabu M, et al. Isolation and characterization of halophilic Bacillus sp.
BS3 able to produce pharmacologically important biosurfactants. Asian Pac
J Trop Med. 2013;6:876–83.
44. Sheppard JD, Jumarie C, Cooper DG, Laprade R. Ionic channels induced by
surfactin in planar lipid bilayer membranes. Biochim Biophys Acta. 1991;1064:13–23.
45. Bizani D, Brandelli A. Characterization of a bacteriocin produced by a newly
isolated Bacillus sp. strain 8A. J Appl Microbiol. 2002;93:512–9.
46. Stein T. Bacillus subtilis antibiotics: structures, syntheses and specific
functions. Mol Microbiol. 2005;56:845–57.
47. Gudiña EJ, Rocha V, Teixeira JA, Rodrigues LR. Antimicrobial and anti-
adhesive properties of a biosurfactant isolated from Lactobacillus paracasei
ssp. paracasei A20. Lett Appl Microbiol. 2010;50:419–24.
48. Rivardo F, Turner RJ, Allegrone G, Ceri H, Martinotti MG. Anti-adhesion activity
of two biosurfactants produced by Bacillus spp. prevents biofilm formation of
human bacterial pathogens. Appl Microbiol Biotechnol. 2009;83:541–53.
49. McLandsborough L, Rodriguez A, Pérez-Conesa D, Weiss J. Biofilms: at
the interface between biophysics and microbiology. Food Biophys.
2006;1:94–114.
50. Boucherit-Atmani Z, Siddiki SML, Boucherit K, Sari-Belkharoubi L, Kunkel D.
candida albicans Biofilms formed into catheters and probes and their
resistance to amphotericin B. J Mycol Med. 2011;21:182–7.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Jemil et al. BMC Microbiology  (2017) 17:144 Page 11 of 11
